CytoDyn (CYDY) Common Equity (2009 - 2026)
CytoDyn (CYDY) recorded Common Equity of -$98.07 million in fiscal Q1 2027 (quarter ended Aug 31, 2026), compared with -$99.51 million a year earlier.
Powered by 
Analysis
CytoDyn (CYDY) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended May 31, 2026), CytoDyn reported Common Equity of -$109.72 million.
- Across earlier fiscal years, Common Equity came in at -$96.04 million in FY2025, -$116.76 million in FY2024, -$109.5 million in FY2023 and -$94.4 million in FY2022.
- The fiscal Q1 2027 figure is the highest quarterly Common Equity since fiscal Q4 2025.
- Per Business Quant, the preceding three fiscal quarters came in at -$109.72 million (Q4 2026), -$104.29 million (Q3 2026) and -$119.75 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | CytoDyn | 334.50 Mn | 285.65 Mn | - | -98.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | -98.07 Mn |
| May 31, 2026 | -109.72 Mn |
| Feb 28, 2026 | -104.29 Mn |
| Nov 30, 2025 | -119.75 Mn |
| Aug 31, 2025 | -99.51 Mn |
| May 31, 2025 | -96.04 Mn |
| Feb 28, 2025 | -92.98 Mn |
| Nov 30, 2024 | -89.39 Mn |
| Aug 31, 2024 | -85.21 Mn |
| May 31, 2024 | -116.76 Mn |
| Feb 29, 2024 | -119.38 Mn |
| Nov 30, 2023 | -114.38 Mn |
| Aug 31, 2023 | -116.89 Mn |
| May 31, 2023 | -109.50 Mn |
| Feb 28, 2023 | -107.01 Mn |
| Nov 30, 2022 | -115.97 Mn |
| Aug 31, 2022 | -94.31 Mn |
| May 31, 2022 | -94.40 Mn |
| Feb 28, 2022 | -22.46 Mn |
| Nov 30, 2021 | -12.70 Mn |
API Access
CytoDyn Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();